Search This Blog

Tuesday, November 12, 2019

Stoke Therapeutics EPS beats by $0.02

Stoke Therapeutics (NASDAQ:STOK): Q3 GAAP EPS of -$0.26 beats by $0.02.
Cash and cash equivalents of $233.05M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)